BioNexus Gene Lab (BGLC) Net Income towards Common Stockholders (2018 - 2026)
BioNexus Gene Lab (BGLC) reported Net Income towards Common Stockholders of -$543575.0 for Q1 2026, up 12.79% on a YoY basis from -$481915.9 in Q1 2025, and up 47.54% sequentially from -$1.0 million in Q4 2025.
BioNexus Gene Lab (BGLC) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 9 years of Net Income towards Common Stockholders data on file, last reported at -$543575.0 in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 12.79% year-over-year to -$543575.0; the trailing twelve-month figure through Mar 2026 stood at -$2.9 million (down 37.16% YoY), and the FY2025 full-year result was -$3.0 million, down 86.73% from the prior year.
- Net Income towards Common Stockholders grew to -$543575.0 in Q1 2026, from -$1.0 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $351515.0 in Q4 2023 to a low of -$2.6 million in Q3 2023.
- A 5-year average of -$463394.4 and a median of -$291231.0 in 2023 frame the typical range for Net Income towards Common Stockholders.
- Peak annual rise in Net Income towards Common Stockholders reached 434.31% in 2023, while the deepest fall reached 3271.0% in 2023.
- Tracing BGLC's Net Income towards Common Stockholders over 5 years: stood at $65788.0 in 2022, then jumped by 434.31% to $351515.0 in 2023, then slumped by 199.09% to -$348319.0 in 2024, then sank by 197.46% to -$1.0 million in 2025, then jumped by 47.54% to -$543575.0 in 2026.
- Business Quant data shows BGLC's Net Income towards Common Stockholders at -$543575.0 in Q1 2026, -$1.0 million in Q4 2025, and -$708991.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | 1.86 Bn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | 534.70 Mn |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | 1.01 Bn |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | 724.80 Mn |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | - |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | 123.00 Mn |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | 402.90 Mn |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | 170.00 Mn |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | 14.00 Mn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | -543,575.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -543,575.00 |
| Dec 31, 2025 | -1.04 Mn |
| Sep 30, 2025 | -708,991.00 |
| Jun 30, 2025 | -616,172.00 |
| Mar 31, 2025 | -623,327.00 |
| Dec 31, 2024 | -348,319.00 |
| Sep 30, 2024 | -1.35 Mn |
| Jun 30, 2024 | 199,104.00 |
| Mar 31, 2024 | -103,757.00 |
| Dec 31, 2023 | 351,515.00 |
| Sep 30, 2023 | -2.61 Mn |
| Jun 30, 2023 | -291,231.00 |
| Mar 31, 2023 | -69,066.00 |
| Dec 31, 2022 | 65,788.00 |
| Sep 30, 2022 | -77,401.00 |
| Jun 30, 2022 | -138,662.00 |
| Mar 31, 2022 | 17,066.00 |
| Dec 31, 2021 | 115,979.00 |
| Sep 30, 2021 | 295,322.00 |
| Jun 30, 2021 | 28,262.00 |